- Investing Ideas
- /
- Pharmaceuticals & Biotech UK Established Discount
Pharmaceuticals & Biotech UK Established Discount
Results
82
0 new
Big ticket companies showing a potential underpricing based on intrinsic value
82 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$161.40 | -1.7% | 3.6% | US$388.5b | US$171.32 | PE23.7x | E7.2% | 3.1% | ||
ABBV | US$194.79 | 0.7% | 30.7% | US$339.0b | US$196.54 | PE64.9x | E25.3% | 3.2% | ||
MRK | US$113.69 | -3.0% | 10.4% | US$286.7b | US$139.03 | PE21x | E14.4% | 2.7% | ||
DHR | US$275.44 | 1.0% | 11.0% | US$200.0b | US$288.05 | PE49x | E14.3% | 0.4% | ||
AMGN | US$322.67 | -4.4% | 20.1% | US$171.5b | US$325.55 | PE55.4x | E23.8% | 2.8% | ||
PFE | US$29.09 | -1.1% | -12.3% | US$164.2b | US$33.56 | PS3x | E32.5% | 5.8% | ||
VRTX | US$462.88 | -0.4% | 33.1% | US$119.5b | US$509.82 | PS11.6x | E46.4% | n/a | ||
REGN | US$1,042.01 | -9.0% | 26.6% | US$112.2b | US$1,157.67 | PE26x | E10.5% | n/a | ||
GILD | US$83.61 | -0.4% | 11.6% | US$103.4b | US$83.54 | PE98.8x | E36.0% | 3.7% | ||
BMY | US$50.91 | 3.0% | -12.3% | US$101.6b | US$53.86 | PS2.2x | E49.0% | 4.7% | ||
ZTS | US$194.81 | 1.1% | 12.0% | US$88.3b | US$213.12 | PE37.7x | E10.2% | 0.9% | ||
IQV | US$234.79 | -3.0% | 19.3% | US$43.1b | US$276.77 | PE30.1x | E13.2% | 0% | ||
ALNY | US$274.91 | 0.4% | 55.2% | US$35.2b | US$285.91 | PS15.1x | E65.2% | n/a | ||
BIIB | US$194.67 | -2.4% | -24.3% | US$28.2b | US$271.25 | PE24.5x | E17.0% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
ICLR | US$285.61 | -5.8% | 16.0% | US$23.7b | US$364.50 | PE33.1x | E14.4% | n/a | ||
TEVA | US$17.46 | -0.3% | 71.2% | US$20.1b | US$21.25 | PS1.2x | E56.8% | 0% | ||
AVTR | US$25.83 | -4.3% | 22.5% | US$17.7b | US$28.57 | PE48.8x | E25.0% | n/a | ||
RPRX | US$28.21 | 2.4% | 3.9% | US$16.7b | US$44.75 | PE18.8x | E11.4% | 3.0% | ||
UTHR | US$358.53 | 1.6% | 58.7% | US$15.9b | US$356.52 | PE14.9x | E6.8% | n/a | ||
RVTY | US$126.06 | 2.6% | 13.9% | US$15.6b | US$133.87 | PE78.8x | E25.8% | 0.2% | ||
VTRS | US$11.55 | 1.4% | 17.1% | US$13.9b | US$12.90 | PB0.7x | E14.4% | 4.2% | ||
BMRN | US$70.58 | -0.2% | -20.2% | US$13.4b | US$104.74 | PE52.4x | E30.0% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a |